Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Avon Names Johnson & Johnson's Sherilyn McCoy As CEO - Quick Facts

RELATED NEWS
Trade JNJ now with 

Johnson & Johnson (JNJ: Quote) said Sherilyn McCoy, Vice Chairman of the Executive Committee, has resigned from the company effective April 18.

Avon Products, Inc. (AVP: Quote), in its press release, said its Board of Directors has appointed Sherilyn McCoy as Chief Executive Officer. McCoy will join Avon effective April 23, 2012, and will also serve as a director on the company's Board.

As previously announced, Andrea Jung, currently Avon's Chairman and CEO, will continue to serve the company as Executive Chairman once McCoy assumes the CEO position. McCoy will report to the company's Board of Directors.

McCoy joined Johnson & Johnson in 1982 and was appointed to her current responsibilities in January, 2011.

William Weldon, JNJ's Chairman and CEO, said McCoy's direct reports will begin reporting immediately to Alex Gorsky, who will become CEO of Johnson & Johnson effective with its Annual Shareholders' Meeting later this month.

Click here to receive FREE breaking news email alerts for Johnson & Johnson and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
This apparel maker has doubled its earnings per share in just two years and increased its annual earnings forecast from time to time, despite a challenging consumer spending environment. Contributions from acquisitions, efficiency gains from self-owned global supply chain and benefits from 'Innovate-to-Elevate' strategy continue to boost the company's results. Here is a quick summary of the earnings reported after the bell on Nov 20. We have 20+ stocks listed here. The good news is you can skip this step. There is a next move that can make your life a lot easier. Our research team has already done the groundwork for you. All these stocks listed... Design software maker Autodesk, Inc. said Thursday after the markets closed that its third quarter profit fell 81% from last year, as higher costs and expenses more than offset an 11% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.